Reply to: "Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?"

Affiliations

¹ AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, INSERM, Unité 1193, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, DHU Hepatinov, Villejuif, France.
² Département d'innovation thérapeutique et d'Essais Précoces (DITEP), Institut Gustave-Roussy, Université Paris Saclay, Villejuif, France.
³ APHP Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, Université Paris Sud, CEA, DSV/iMETI, Division of Immunovirology, IDMIT, INSERM, U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin Bicêtre, France.
⁴ Dermatology Unit, Department of Medical Oncology, Gustave Roussy, Paris Sud University, Villejuif, France.
⁵ AP-HP Hôpital Bicêtre, Department of Pathology, Le Kremlin-Bicêtre, France, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, France.
⁶ AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, INSERM, Unité 1193, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, DHU Hepatinov, Villejuif, France. Electronic address: didier.samuel@pbr.aphp.fr.

Comment

Eleonora De Martin et al. J Hepatol. 2018 Aug.

. 2018 Aug;69(2):550-551.

doi: 10.1016/j.jhep.2018.04.019.

¹ AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, INSERM, Unité 1193, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, DHU Hepatinov, Villejuif, France.
² Département d'innovation thérapeutique et d'Essais Précoces (DITEP), Institut Gustave-Roussy, Université Paris Saclay, Villejuif, France.
³ APHP Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, Université Paris Sud, CEA, DSV/iMETI, Division of Immunovirology, IDMIT, INSERM, U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin Bicêtre, France.
⁴ Dermatology Unit, Department of Medical Oncology, Gustave Roussy, Paris Sud University, Villejuif, France.
⁵ AP-HP Hôpital Bicêtre, Department of Pathology, Le Kremlin-Bicêtre, France, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, France.
⁶ AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, INSERM, Unité 1193, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, DHU Hepatinov, Villejuif, France. Electronic address: didier.samuel@pbr.aphp.fr.

No abstract available

Comment on

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
De Martin E, Michot JM, Papouin B, Champiat S, Mateus C, Lambotte O, Roche B, Antonini TM, Coilly A, Laghouati S, Robert C, Marabelle A, Guettier C, Samuel D. De Martin E, et al. J Hepatol. 2018 Jun;68(6):1181-1190. doi: 10.1016/j.jhep.2018.01.033. Epub 2018 Feb 8. J Hepatol. 2018. PMID: 29427729
Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?
Gauci ML, Baroudjian B, Zeboulon C, Pages C, Poté N, Roux O, Bouattour M, Lebbé C; PATIO group. Gauci ML, et al. J Hepatol. 2018 Aug;69(2):548-550. doi: 10.1016/j.jhep.2018.03.034. Epub 2018 May 7. J Hepatol. 2018. PMID: 29747956 No abstract available.